Netherton Syndrome Ns clinical trials

Explore recruiting netherton syndrome ns clinical trials.

Also recruiting in Europe

Netherton Syndrome Ns trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Evasayil TM: A placebo-controlled trial to evaluate the efficacy and safety of spesolimab in the treatment of patients with Netherton syndrome

Spain, Belgium, Bulgaria, Germany, Italy, Finland +5 more

Phase II and Phase III (Integrated) EU CTIS Study details

A phase I/II, multicenter, randomized, double-blind, placebo within-patient controlled, first-in-human (FIH) Proof of Concept (PoC) study to evaluate the safety and efficacy of topically applied SXR1096 cream in patients with Netherton syndrome (NS)

Germany, France, Austria, Sweden

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Netherton Syndrome Ns trials by city

Netherton Syndrome Ns in Toronto Netherton Syndrome Ns in Vancouver Netherton Syndrome Ns in Montreal Netherton Syndrome Ns in Calgary Netherton Syndrome Ns in Edmonton Netherton Syndrome Ns in Ottawa Netherton Syndrome Ns in Winnipeg Netherton Syndrome Ns in Quebec City Netherton Syndrome Ns in Hamilton Netherton Syndrome Ns in Kitchener Netherton Syndrome Ns in London Netherton Syndrome Ns in Halifax Netherton Syndrome Ns in New York Netherton Syndrome Ns in Los Angeles Netherton Syndrome Ns in Chicago Netherton Syndrome Ns in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease